Chemomab Therapeutics Ltd. (CMMB) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Chemomab Therapeutics Ltd...

    NASDAQ: CMMB · Real-Time Price · USD
    2.72
    0.02 (0.74%)
    At close: Oct 03, 2025, 3:59 PM
    2.71
    -0.37%
    After-hours: Oct 03, 2025, 04:37 PM EDT

    Chemomab Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 6.07M 9.29M 13.52M 14.69M
    Short-Term Investments
    		 8.2M 10.49M 26.37M 45.98M
    Long-Term Investments
    		 n/a n/a n/a 55K
    Other Long-Term Assets
    		 378.38K 550.98K 719K 894K
    Receivables
    		 263K 289K 459K 179K
    Inventory
    		 n/a n/a n/a -1.35M
    Other Current Assets
    		 76K 76K 77K 1.35M
    Total Current Assets
    		 16.04M 20.9M 41.74M 62.69M
    Property-Plant & Equipment
    		 539K 695K 594K 702K
    Goodwill & Intangibles
    		 6.62K 8.02K 14K 14K
    Total Long-Term Assets
    		 924K 1.25M 1.33M 1.67M
    Total Assets
    		 16.96M 22.15M 43.06M 64.35M
    Account Payables
    		 666K 516K 1.69M 1.34M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 115K 76K 123K 106K
    Other Current Liabilities
    		 759K 747K -123K -106K
    Total Current Liabilities
    		 3.22M 4.84M 6.75M 2.65M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 209K 316K 91K 237K
    Total Liabilities
    		 3.43M 5.15M 6.84M 2.89M
    Total Debt
    		 324K 392K 214K 343K
    Book Value
    		 13.54M 17M 36.22M 61.47M
    Book Value Per Share
    		 0.75 1.45 3.18 5.93
    Common Stock
    		 n/a n/a n/a n/a
    Retained Earnings
    		 -102.62M -88.68M -63.82M -36.17M
    Comprehensive Income
    		 n/a n/a n/a n/a
    Shareholders Equity
    		 13.54M 17M 36.22M 61.47M
    Total Investments
    		 8.2M 10.49M 26.37M 46.48M

    Add to Watchlist